Abstract
Thoracic minimally invasive surgery has some proved postoperative advantages. Robotic-assisted thoracic surgery has brought relevant technical improvements with consistent equivalence in oncologic results when compared to video-assisted surgery. Despite these potential benefits of robotic surgery, the cost was still considered a limiting factor for the wide dissemination of the technique in many countries. This study evaluate the cost difference between pulmonary lobectomy in patients included in a randomized controlled trial that compared video-assisted and robotic-assisted lobectomy in lung cancer and lung metastases resection.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
